|
TMEM50A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.663400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.135300E-03 |
| Normal-vs-Stage2 |
1.466160E-01 |
| Normal-vs-Stage3 |
1.488850E-01 |
| Normal-vs-Stage4 |
1.954190E-01 |
| Stage1-vs-Stage2 |
6.513000E-01 |
| Stage1-vs-Stage3 |
3.744200E-01 |
| Stage1-vs-Stage4 |
7.670200E-01 |
| Stage2-vs-Stage3 |
8.826400E-01 |
| Stage2-vs-Stage4 |
9.656600E-01 |
| Stage3-vs-Stage4 |
8.654000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.396900E-03 |
| Normal-vs-AfricanAmerican |
2.474300E-02 |
| Normal-vs-Asian |
2.851400E-01 |
| Caucasian-vs-AfricanAmerican |
8.832600E-01 |
| Caucasian-vs-Asian |
7.385000E-01 |
| AfricanAmerican-vs-Asian |
6.373600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.477800E-02 |
| Normal-vs-Female |
4.573600E-04 |
| Male-vs-Female |
2.606000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.267380E-01 |
| Normal-vs-Extreme_Weight |
2.282300E-02 |
| Normal-vs-Obese |
8.303800E-03 |
| Normal-vs-Extreme_Obese |
9.829600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.843600E-01 |
| Normal_Weight-vs-Obese |
7.174200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.121600E-01 |
| Extreme_Weight-vs-Obese |
5.812400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.632600E-01 |
| Obese-vs-Extreme_Obese |
1.679400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.718050E-02 |
| Normal-vs-Age(41-60Yrs) |
2.177700E-04 |
| Normal-vs-Age(61-80Yrs) |
5.714100E-02 |
| Normal-vs-Age(81-100Yrs) |
5.567200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.769400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.933800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.606770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.320290E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.183800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.963400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.9048000000026E-05 |
| Normal-VS-Type2 PRCC |
7.166800E-01 |
| Normal-VS-KIRP CIMP |
2.187700E-04 |
| Normal-VS-Unclassified PRCC |
1.030440E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.06909999975491E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.972800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.907800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.236700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.457420E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.638600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.032250E-01 |
| Normal-vs-N1 |
1.058750E-01 |
| Normal-vs-N2 |
9.157600E-02 |
| N0-vs-N1 |
9.785600E-01 |
| N0-vs-N2 |
5.152200E-01 |
| N1-vs-N2 |
4.266000E-01 |
|
|
